Atlas Trials

A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls

Clinical trial NCT04494269 · UNKNOWN

Trial details

NCT number
NCT04494269
Sponsor
HK inno.N Corporation
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic ImpairmentHealthy
Start date
2020-09-08
Primary completion
2023-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.